Bausch + Lomb Total Current Assets 2021-2024 | BLCO

Bausch + Lomb total current assets from 2021 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
  • Bausch + Lomb total current assets for the quarter ending September 30, 2024 were $2.828B, a 14.77% increase year-over-year.
  • Bausch + Lomb total current assets for 2023 were $2.742B, a 28.31% increase from 2022.
  • Bausch + Lomb total current assets for 2022 were $2.137B, a 30.7% increase from 2021.
  • Bausch + Lomb total current assets for 2021 were $1.635B, a 1.15% decline from 2020.
Bausch + Lomb Annual Total Current Assets
(Millions of US $)
2023 $2,742
2022 $2,137
2021 $1,635
2020 $1,654
Bausch + Lomb Quarterly Total Current Assets
(Millions of US $)
2024-09-30 $2,828
2024-06-30 $2,769
2024-03-31 $2,743
2023-12-31 $2,742
2023-09-30 $2,464
2023-06-30 $2,315
2023-03-31 $2,184
2022-12-31 $2,137
2022-09-30 $1,859
2022-06-30 $2,001
2022-03-31 $1,719
2021-12-31 $1,635
2021-09-30
2021-06-30
2021-03-31
2020-12-31 $1,654
Sector Industry Market Cap Revenue
Medical Medical Services $6.977B $4.146B
Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R). Bausch Lomb Corporation is based in VAUGHAN, ON.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $93.604B 11.61
Cencora (COR) United States $48.412B 17.85
DiDi Global (DIDIY) China $22.941B 0.00
Natera (NTRA) United States $22.359B 0.00
ICON (ICLR) Ireland $17.552B 15.63
Viatris (VTRS) United States $15.815B 4.87
Avantor (AVTR) United States $13.857B 20.78
Revvity (RVTY) United States $13.522B 23.49
CochLear (CHEOY) Australia $12.586B 0.00
BioMerieux (BMXMF) France $12.119B 0.00
Solventum (SOLV) United States $12.029B 0.00
Medpace Holdings (MEDP) United States $10.624B 29.93
Charles River Laboratories (CRL) United States $9.930B 19.19
HealthEquity (HQY) United States $9.139B 49.60
Doximity (DOCS) United States $8.961B 52.75
Sonic Healthcare (SKHHY) Australia $8.813B 0.00
Life Times (LTH) United States $5.046B 33.40
Organon (OGN) United States $3.835B 3.87
Sotera Health (SHC) United States $3.515B 18.80
BrightSpring Health Services (BTSG) United States $3.265B 69.44
Surgery Partners (SGRY) United States $2.968B 33.84
Concentras Parent (CON) United States $2.735B 0.00
PACS (PACS) United States $2.522B 0.00
Alignment Healthcare (ALHC) United States $2.320B 0.00
Ardent Health Partners (ARDT) United States $2.255B 0.00
Premier (PINC) United States $2.155B 11.21
Ryman Healthcare (RYHTY) New Zealand $1.995B 0.00
GeneDx Holdings (WGS) United States $1.980B 0.00
Teladoc Health (TDOC) United States $1.791B 0.00
GoodRx Holdings (GDRX) United States $1.635B 42.90
Progyny (PGNY) United States $1.275B 25.81
Pediatrix Medical (MD) United States $1.267B 12.40
CareDx (CDNA) United States $1.211B 0.00
Establishment Labs Holdings (ESTA) $1.193B 0.00
AMN Healthcare Services Inc (AMN) United States $0.978B 6.62
Embecta (EMBC) United States $0.808B 5.38
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.733B 0.00
SBC Medicals (SBC) United States $0.670B 0.00
InnovAge Holding (INNV) United States $0.627B 0.00
Auna S.A (AUNA) Luxembourg $0.526B 0.00
Sonida Senior Living (SNDA) United States $0.467B 0.00
DocGo (DCGO) United States $0.420B 15.85
Enhabit (EHAB) United States $0.376B 32.48
COMPASS Pathways (CMPS) United Kingdom $0.304B 0.00
ModivCare (MODV) United States $0.250B 13.54
LifeMD (LFMD) United States $0.246B 0.00
Sera Prognostics (SERA) United States $0.206B 0.00
Biodesix (BDSX) United States $0.175B 0.00
Nutex Health (NUTX) United States $0.173B 0.00
Beauty Health (SKIN) United States $0.173B 0.00
MultiPlan (MPLN) United States $0.114B 0.00
Ascend Wellness Holdings (AAWH) United States $0.094B 0.00
So-Young (SY) China $0.093B 17.98
Singular Genomics Systems (OMIC) United States $0.055B 0.00
OncoCyte (OCX) United States $0.045B 0.00
NeueHealth (NEUE) United States $0.042B 1.11
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.031B 0.00
IceCure Medical (ICCM) Israel $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.022B 0.00
Oncology Institute (TOI) United States $0.012B 0.00
SeaStar Medical Holding (ICU) United States $0.010B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
KindlyMD (KDLY) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00